Certuity LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Certuity LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,199 shares of the medical equipment provider’s stock after purchasing an additional 252 shares during the period. Certuity LLC’s holdings in Intuitive Surgical were worth $742,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of ISRG. Baystate Wealth Management LLC increased its holdings in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares during the last quarter. MCF Advisors LLC increased its holdings in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares during the last quarter. Atticus Wealth Management LLC grew its holdings in Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 41 shares in the last quarter. OFI Invest Asset Management bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $25,000. Finally, Headinvest LLC purchased a new position in shares of Intuitive Surgical in the third quarter valued at $28,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $370.62 on Wednesday. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The stock has a market cap of $131.46 billion, a PE ratio of 66.90, a price-to-earnings-growth ratio of 4.83 and a beta of 1.36. The stock has a 50-day moving average of $385.96 and a two-hundred day moving average of $348.19.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the business posted $1.00 earnings per share. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $375.39, for a total value of $141,146.64. Following the sale, the executive vice president now directly owns 5,507 shares in the company, valued at approximately $2,067,272.73. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $375.39, for a total transaction of $141,146.64. Following the sale, the executive vice president now owns 5,507 shares of the company’s stock, valued at $2,067,272.73. The disclosure for this sale can be found here. Insiders have sold a total of 226,967 shares of company stock valued at $87,848,586 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. Piper Sandler raised their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Citigroup increased their price target on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Finally, BTIG Research increased their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.